Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.

ABSTRACT:

SUBMITTER: Guest EM 

PROVIDER: S-EPMC5561899 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature